Skip to main content

Bird Reports 2026 First Quarter Results; 9% Revenue Growth and Record Backlog

MISSISSAUGA, Ontario, May 13, 2026 (GLOBE NEWSWIRE) — “Bird delivered a strong start to 2026, with organic revenue growth, stable margins and solid cash flow that reflect the resilience of our diversified One Bird platform,” said Teri McKibbon, President and CEO of Bird Construction. “Record contracted backlog and a sizable pending backlog provide clear visibility into future activity and demonstrate continued demand across our key strategic sectors. Supported by a strong balance sheet and ample liquidity, we remain focused on safe execution and continued margin accretion as we advance toward achieving our 2027 Strategic Plan objectives.” FINANCIAL HIGHLIGHTSBird reported first quarter revenue growth of 9.2% compared to the first quarter of 2025. Strong organic revenue growth in the Buildings business was partially offset...

Continue reading

National Healthcare Properties Reports First Quarter 2026 Results

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHP) (the “Company”), a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States, today announced results for the quarter ended March 31, 2026. Michael Anderson, Chief Executive Officer and President, commented, “Our IPO marks the culmination of years of work to position this Company for growth and is just the beginning of what comes next. We are highly confident in our ability to create shareholder value by executing on significant OMF dispositions and SHOP acquisitions in 2026, decisively orienting our portfolio toward the generational opportunity we see in...

Continue reading

Mattr Announces First Quarter 2026 Results: Strengthening Composite Technologies Performance Drives Sequential Growth and Improved Full Year Outlook

TORONTO, May 13, 2026 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) reported today its operational and financial results for the three months ended, March 31, 2026. This press release should be read in conjunction with the Company’s Management Discussion and Analysis (“MD&A”) and unaudited condensed interim consolidated financial statements for the three months ended March 31, 2026, which are available on the “Investor Center” page of the Company’s website and at www.sedarplus.ca. “Mattr delivered strong sequential revenue and margin growth in the first quarter, reflecting continued demand for our differentiated infrastructure products and improving operational efficiency, particularly within the Composite Technologies segment,” said Mike Reeves, President & CEO. “Typical first-quarter seasonal...

Continue reading

Phoenix Energy Reports Q1 2026 Financial and Operating Results

IRVINE, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Phoenix Energy One, LLC (NYSE American, PHXE.P) (“Phoenix Energy” or the “Company”), an energy company focused on oil and gas exploration and production across key U.S. basins, with a primary footprint in the Williston Basin in North Dakota and Montana, filed its Quarterly Report for the three months ended March 31, 2026 on May 13, 2026, thereby announcing its financial and operating results for the first quarter of 2026. Q1 2026 HighlightsGenerated revenue of $298.7 million in Q1 2026 as compared to $115.7 million in Q1 2025, net loss of $140.1 million as compared to net income of $5.6 million in Q1 2025, EBITDA of $(27.6) million as compared to $72.0 million in Q1 2025, and Adjusted EBITDA of $130.2 million as compared to $69.2 million in Q1 2025; Amended the Company’s term...

Continue reading

ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion. Inflammasome ASC Inhibitor IC 100 is the next evolution of inflammasome inhibitors designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes activated in numerous diseases, not just NLRP3, and (2) attenuating spread and perpetuation of inflammation by uniquely inhibiting ASC specks.Lead indication: Cardiometabolic conditions associated with obesity Value driving milestones: file IND Q4-2026; Phase 1 SAD read-out H1-2027Cholesterol Efflux Mediator VAR 200 is expected to be a disease-modifying renal drug by targeting unaddressed renal lipotoxicity to attenuate renal damage and slow disease progression.Lead indication: orphan disease FSGS (focal...

Continue reading

TerraForm Power Operating First Quarter 2026 Results Webcast and Conference Call

Date: Wednesday, May 20, 2026Time: 3:00 pm (Eastern Time) NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — You are invited to participate in TerraForm Power Operating, LLC’s First Quarter 2026 Results Webcast and Conference Call on May 20, 2026 at 3:00 p.m. (Eastern Time) to discuss results and current business initiatives with senior management. These results will be made available on our website at www.terraform.com in the form of unaudited consolidated financial statements for the periods ended March 31, 2026 and 2025 under “Financials” prior to the webcast and conference call. Participants can join by conference call or webcast: Conference Call Please pre-register by conference call clicking here Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN. This process will bypass the operator and avoid...

Continue reading

Planet 13 Announces Q1 2026 Financial Results

Q1 2026 Revenue of $21.1 million Q1 2026 Net loss of $8.1 million Q1 2026 Adjusted EBITDA loss of $2.3 millionAll figures are reported in United States dollars ($) unless otherwise indicated LAS VEGAS, May 13, 2026 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended March 31, 2026. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). “Q1 was a transition quarter that reflected the cost of the strategic work we executed over the past several quarters including the California exit, the Wagon Trail consolidation in Nevada, and the disciplined cost reduction across the organisation....

Continue reading

Battalion Oil Corporation Announces First Quarter 2026 Financial and Operating Results

HOUSTON, May 13, 2026 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the first quarter of 2026. Key HighlightsThe Company ended the quarter with positive equity of $157.1 million. This provides further basis for the Company to attain compliance with NYSE listing requirements Reduced net debt (gross debt less cash and reinvestment proceeds) to $108.3 million vs $180.2 million in Q4 2025 Divested West Quito Assets for net proceeds of $60.1 million, utilizing $45.6 million to repay amounts outstanding under our Term Loan Executed a private placement to an institutional investor for purchase of common stock at $5.50 per share for total gross proceeds of $15.0 million Converted 7,803 shares of preferred stock to 1.8 million common...

Continue reading

Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights

– Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 – – FDA feedback on use of new form of brilaroxazine in the RECOVER-2 trial and future NDA expected in mid-2026 –– Initiation of patient enrollment in RECOVER-2 registrational Phase 3 trial expected Q3 2026 – CUPERTINO, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today reported financial results for the first quarter ended March 31, 2026 and summarized recent business highlights. “During...

Continue reading

Global Water Resources Reports First Quarter 2026 Results

PHOENIX, May 13, 2026 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the first quarter ended March 31, 2026. Unless otherwise noted, all comparisons are to the corresponding period in the prior year. The company will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Q1 2026 Financial HighlightsTotal revenue increased 6.7% year-over-year (“YoY”) to $13.3 million. The increase was primarily due to the acquisition of seven water systems from Tucson Water in July 2025, organic connection growth, increased consumption and higher rates. Net loss totaled $0.4 million or ($0.01) per share, a decrease of $1.0 million YoY compared to net income of $0.6 million or $0.02 per share in the first...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.